Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ISI established to fund cardiovascular technologies:

This article was originally published in Clinica

Executive Summary

Trevi Health Ventures, a transatlantic healthcare private equity firm, has teamed up with medtech entrepreneur Peter Hinchliffe to form Interventional & Surgical Innovations (ISI), a development platform company for early-stage medical technologies. With its initial focus on the cardiovascular market, ISI will provide funding to take early technologies through to the proof-of-concept stage, with the goal of spinning out the end products into a series of separately-financed entities. The company has already acquired licences to several technologies that are being developed by Prof Frans Moll at Utrecht University in the Netherlands. As part of the strategic partnership with the university, Prof Moll will be key clinical advisor to ISI. The firm will be managed by Mr Hinchliffe , who has held senior roles in the interventional and intervascular divisions of Datascope and in the US Surgical division of Tyco.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT047583

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel